Abbott Taps Celera Spinout to Replace Legacy Discovery Software with Integrative Platform

An Abbott official said that the Seurat system from Synaptic Science is "significantly" lower in cost than Abbott's legacy system — a blend of in-house software and the MDL Isis client — and was compatible "out-of-the-box" with Abbott's internal and industry standards.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.